SCHEMBL4630723

SCHEMBL4630723

O=C1COC(CC[N+]23CCC(Cc4ccccc4)(CC2)CC3)(c2ccc(F)c(F)c2)CN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.36
FPR1 P21462 1/20 0.36
GPR183 P32249 1/20 0.36
APLNR P35414 1/20 0.36
GLP1R P43220 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
GPR35 Q9HC97 1/20 0.36
CYP3A4 P08684 2/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP2D6 P10635 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
USP2 O75604 2/20 0.31
TACR1 P25103 2/20 0.30
TSHR P16473 1/20 0.30
SIRT2 Q8IXJ6 1/20 0.30
SIRT1 Q96EB6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7750351 0.98 ADRB2 (0.37) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4631313 0.91 ADRB2 (0.37) ADRB2FPR1GPR183APLNRGLP1R
Water SCHEMBL7749198 0.89 ADRB2 (0.38) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4630773 0.81 TACR1 (0.38) ADRB2FPR1GPR183APLNRGLP1R
Water SCHEMBL7749169 0.80 TACR1 (0.37) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL7750393 0.80 ADRB2 (0.39) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4631605 0.80 TACR1 (0.34) CYP3A4ALDH1A1CYP2D6SMN1; SMN2TACR1
SCHEMBL4630794 0.79 HSD11B1 (0.34) ADRB2FPR1GPR183APLNRGLP1R
Hydrochloric Acid SCHEMBL7750338 0.79 ADRB2 (0.34) ADRB2FPR1GPR183APLNRGLP1R
Water SCHEMBL7749122 0.79 TACR1 (0.34) CYP3A4ALDH1A1CYP2D6SMN1; SMN2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1923391-A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. sanofi-aventis (FR) 2008-05-21 EP disclosed
EP-1340754-A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2003-09-03 EP disclosed
EP-1156049-A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2001-11-21 EP disclosed
WO-1996023787-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI (FR) 1996-08-08 WO disclosed